Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicskin HoldingsHKSE:08307 54 EV-to-FCF is 11.69 as of Aug. 12, 2026, which is 9% above its 10-year median of 10.71. GuruFocus rates HKSE:08307 with a GF Score™ of 54/100 and a GF Value™ of HK$0.18 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 407 Healthcare Providers & Services companies, Medicskin Holdings ranks better than 67.08% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medicskin Holdings's Enterprise Value is HK$49.64 Mil.
Medicskin Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was HK$4.25 Mil. Therefore, Medicskin Holdings's EV-to-FCF for today is 11.69.
The historical rank and industry rank for Medicskin Holdings's EV-to-FCF or its related term are showing as below:
HKSE:08307'
s EV-to-FCF Range Over the Past 10 Years
Min: -145.05 Med: 10.71 Max: 608.85
Current: 11.69
During the past 13 years, the highest EV-to-FCF of Medicskin Holdings was 608.85. The lowest was -145.05. And the median was 10.71.
HKSE:08307's EV-to-FCF is ranked better than 67.08% of 407
companies
in the Healthcare Providers & Services industry
Industry Median: 18.75
vs HKSE:08307: 11.69
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medicskin Holdings's PE Ratio (TTM) for today is calculated as:
Medicskin Holdings's share price for today is HK$0.123.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medicskin Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was HK$0.002.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medicskin Holdings EV-to-FCF Related Terms
Medicskin Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Medicskin Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Medicskin Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicskin Holdings EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicskin Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medicskin Holdings's EV-to-FCF falls into.
Medicskin Holdings's current Enterprise Value is HK$49.64 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medicskin Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was HK$4.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicskin Holdings (HKSE:08307) has a EV-to-FCF of 11.69 as of Aug. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medicskin Holdings and its competitors. This is near median its historical median of 10.71. According to the industry distribution chart, Medicskin Holdings ranks #134 out of 407 companies in the Healthcare Providers & Services industry, placing it in the top 32.9%.
Is Medicskin Holdings' EV-to-FCF too high?
Medicskin Holdings' current EV-to-FCF of 11.69 is near median its 10-year median of 10.71. The Healthcare Providers & Services industry median EV-to-FCF is 18.75. Medicskin Holdings' value of 11.69 is 37.7% below this industry median. Based on the distribution chart, Medicskin Holdings ranks #134 out of 407 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medicskin Holdings has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medicskin Holdings' EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicskin Holdings ranks #134 out of 407 companies for EV-to-FCF. This puts Medicskin Holdings in the upper half of its industry. The industry median EV-to-FCF is 18.75. Medicskin Holdings' value of 11.69 is 37.7% below this benchmark. While the company's 10-year median is 10.71 vs. the industry median of 18.75, Medicskin Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.75, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicskin Holdings's current EV-to-FCF of 11.69 is 37.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medicskin Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicskin Holdings's current EV-to-FCF is 11.69, which is near median its own 10-year median of 10.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicskin Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medicskin Holdings (HKSE:08307) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.18, compared to a current price of HK$0.12 — trading 31.7% below its estimated fair value. The current EV-to-FCF is 11.69, which is near median its 10-year median of 10.71 and 37.7% below the Healthcare Providers & Services industry median of 18.75. Medicskin Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medicskin Holdings (HKSE:08307), the current EV-to-FCF is 11.69 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicskin Holdings (HKSE:08307) Overvalued in 2026?
Based on GuruFocus' analysis, Medicskin Holdings stock appears to be undervalued.
The current stock price of HK$0.12 is trading 31.7% below its estimated GF Value™ of HK$0.18.
GuruFocus considers Medicskin Holdings to be Possible Value Trap.
Key valuation signals for HKSE:08307:
EV-to-FCF: 11.69 (near median its 10-year median of 10.71)
GF Value™: HK$0.18 vs. price of HK$0.12 (31.7% below fair value)
Industry Position: 37.7% below the Healthcare Providers & Services median (#134 of 407)
No single metric tells the full story. See the HKSE:08307 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicskin Holdings Ltd is a medical skin care service provider. It is engaged in providing services for inter alia, acne, pigmentation, rosacea, dermatitis, eczema and warts, skin rejuvenation, facial sculpturing and body contouring, treatment for acne scars and enlarged pores, removal of undesirable naevi, and hair removal. The company operates through a single segment namely Consultation Service, Prescription and Dispensing Service, and Treatment Services. The company offers services throughout Hong Kong.
54GF Score
Get the complete analysis for HKSE:08307
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08307 has been successfully added to your 
